2
Participants
Start Date
March 31, 2010
Primary Completion Date
March 31, 2011
Study Completion Date
June 30, 2012
bortezomib
1.3 mg/m\^2, by IV on days 1, 8 and 15 every 28 days
cyclophosphamide
300 mg/m\^2, orally, on days 1, 8, 15 \& 22 every 28 days.
dexamethasone
40 mg, orally, on days 1, 8, 15 \& 22 every 28 days
Mayo Clinic, Rochester
Lead Sponsor
Mayo Clinic
OTHER